Skip to main content

Featured

Houthis Signal Readiness for Iran Conflict, Heightening Global Shipping Fears Article

Houthi activists burn US and Israeli flags during a demonstration in solidarity with Iran and Lebanon, in Sanaa, Yemen. Yemen’s Iran‑aligned Houthi movement has declared it is prepared to join the escalating conflict involving Iran, a move that could further destabilize global shipping routes and intensify economic pressures. A senior Houthi figure told Reuters the group is “fully militarily ready with all options,” noting that any decision to act would depend on developments in the wider regional war.  The Houthis, who previously disrupted Red Sea traffic during the Gaza conflict, may once again target the Bab al‑Mandab Strait—one of the world’s most critical maritime chokepoints. The narrow passage connects the Red Sea to the Suez Canal, and renewed attacks could deepen the global oil and trade crisis already triggered by the Middle East conflict. Analysts suggest the group may be waiting for a strategic moment to open a new front in coordination with Iran, especially as the ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment